Gastroenterology

Ann Moyer, M.D., Ph.D., discusses an additional gene, NUDT15, which is important in the prediction of thiopurine-related toxicity This gene has been added to our TPMT genotyping assay available through Mayo Medical Laboratories.

By mayocliniclabs • October 25, 2017

This “Specialty Testing” webinar describes a new serum test for bile acid malabsorption. Descriptions illustrate how the test can be used as a screening test and as a tool for therapeutic action.

By MCL Education • October 19, 2017

This week’s Research Roundup highlights autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn’s disease.

By Kelley Luedke • September 11, 2017

Leslie Donato, Ph.D., DABCC, Co-Director of the Cardiovascular Laboratory Medicine and Co-Director of the Hospital Clinical Laboratory and Point-of-Care Testing at Mayo Clinic in Rochester, recently authored an article in Clinical Laboratory News on irritable bowel syndrome.

By Kelley Luedke • May 11, 2017

This week’s Research Roundup highlights autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn’s disease.

By Kelley Luedke • April 17, 2017

Why is TPMT Testing Important? Detection of individuals with low thiopurine methyltransferase (TPMT) activity who […]

By mayocliniclabs • March 29, 2017

Mayo Clinic has completed validation of its existing Infliximab Quantitation with Reflex to Antibodies to […]

By mayocliniclabs • March 7, 2017

View this week’s case by Sadia Sayeed, M.D., and Roger Moreira, M.D., and make your diagnosis.

By Rene Revier • January 10, 2017

This week’s Research Roundup highlights the development of a microscopic colitis disease activity index.

By Kelley Luedke • December 19, 2016

This week’s Research Roundup highlights the presence of intraepithelial food antigen in patients with active eosinophilic oesophagitis.

By Kelley Luedke • December 5, 2016

The differential diagnosis for inflammatory bowel disease (IBD) includes irritable bowel syndrome (IBS). While the clinical presentation is similar, IBD is an inflammatory disease, while IBS is a noninflammatory disease. View this “Hot Topic” to learn about testing for IBD and IBS.

By MCL Education • September 6, 2016

Mayo Clinic researchers conducted a thorough review to examine diagnostic testing strategies for celiac disease, focusing on published guidelines, for the evaluation of patients with suspected celiac disease.

By Kelley Luedke • May 9, 2016

The new Gastrointestinal Pathogen Panel, PCR, Feces test is now available to the Mayo Clinic practice and Mayo Medical Laboratories clients.

By brentwestra • March 10, 2016